Effects of Ibutilide on Canine Cardiac Pacing Threshold and on Induction Rates of Atrial Fibrillation

被引:1
作者
Sun, Jian-ling [1 ]
Han, Rong [2 ]
Guo, Ji-hong [3 ]
Li, Xiao-ying [4 ]
Ma, Xian-lin [5 ]
Wang, Chong-yu [1 ]
机构
[1] Aviat Gen Hosp, Dept Cardiol, Beijing 100012, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 6, Dept Chinese Internal Med, Urumqi 830002, Peoples R China
[3] Peking Univ, Peoples Hosp, Dept Cardiol, Electrophysiol Grp, Beijing 100871, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China
[5] Beijing Jian Gong Hosp, Dept Cardiol, Beijing, Peoples R China
关键词
Cardiology; Ibutilide; Canines; Electrophysiological character; Animal models; Pacing threshold; Atrial fibrillation; CARDIOVERSION; EFFICACY; FLUTTER; SAFETY; DRUG;
D O I
10.1007/s12013-012-9372-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aims to observe the effects of ibutilide on canine cardiac pacing threshold and on induction rates of atrial fibrillation. Eighteen mongrel dogs were anesthetized and administrated with ibutilide. The pacing thresholds and induction rates of atrial fibrillation were measured with and without ibutilide (10-min infusion dose was 0.10 mg kg(-1), followed by a maintaining dose of 0.01 mg min(-1) 30 min later). This study found that ibutilide increases pacing thresholds in dogs. Moreover, there were significant differences between pacing thresholds with and without ibutilide (P < 0.05). Further, ibutilide significantly reduces the induction rates of atrial fibrillation (P < 0.05). Our findings indicate that pacing voltage changes should be closely monitored in patients taking anti-arrhythmic drugs, who are treated with cardiac stimulation or have undergone pacemaker implantation. We also found that ibutilide is an effective drug in preventing or controlling atrial fibrillation.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 14 条
  • [1] Efremidis M, 2004, MED SCI MONITOR, V10, pCR258
  • [2] Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone
    Fragakis, N
    Papadopoulos, N
    Papanastasiou, S
    Kozirakis, M
    Maligkos, G
    Tsaritsaniotis, E
    Katsaris, G
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (09): : 954 - 961
  • [3] Jianling S., 2005, CHINESE CARDIAC PACI, V4, P284
  • [4] EPIDEMIOLOGIC FEATURES OF CHRONIC ATRIAL-FIBRILLATION - THE FRAMINGHAM-STUDY
    KANNEL, WB
    ABBOTT, RD
    SAVAGE, DD
    MCNAMARA, PM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (17) : 1018 - 1022
  • [5] Rapid decline in acute stimulation thresholds with steroid-eluting active-fixation pacing leads
    Kistler, PM
    Kalman, JM
    Fynn, SP
    Singarayar, S
    Roberts-Thomson, KC
    Lindsay, CB
    Khong, U
    Sparks, PB
    Strathmore, N
    Mond, HG
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (09): : 903 - 909
  • [6] Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro
    Kovács, A
    Gyönös, I
    Magyar, J
    Bányász, T
    Nánási, PP
    Spedding, M
    Szénási, G
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (01) : 78 - 88
  • [7] Lee KS, 1998, J PHARMACOL EXP THER, V286, P9
  • [8] Murray KT, 1998, CIRCULATION, V97, P493
  • [9] Spatial distribution and frequency dependence of arrhythmogenic vagal effects in canine atria
    Sharifov, OF
    Zaitsev, AV
    Rosenshtraukh, LV
    Kaliadin, AY
    Beloshapko, GG
    Yushmanova, AV
    Schuessler, RB
    Boineau, JP
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (09) : 1029 - 1042
  • [10] Shuyun X., 1982, PHARM EXPT METHODOLO, P1184